GoldBamboo.com - Knowledge is strong medicine
  

Gaucher disease, type 3 - Blogs


  Not Signed In - Sign In / Register


Get Your Free Credit Report Right Now!

Zip Code:





Gaucher disease, type 3

Norrbottnian Gaucher disease; Subacute Neuronopathic Gaucher Disease; Type 3 Gaucher Disease 



Recent Blog Posts



View Post: FDA Grants Priority Review for Shire's velaglucerase alfa for Type ...
11 Nov 2009 by DoctorFrog  
Gaucher disease has classicallybeen categorized into 3 clinical types. Type 1 is the most common; it isdistinguished from Type 2 and Type 3 by the lack of central nervous systeminvolvement. Type 1 Gaucher disease is characterized by ...
View Blog: Procto-Med - http://www.procto-med.com/



View Post: Social Security, Compassionate Allowances - hadit.com Veterans Forum
23 hours ago
3. Alexander Disease (ALX) - Neonatal and Infantile. 4. Amyotrophic Lateral Sclerosis (ALS). 5. Anaplastic Adrenal Cancer - with distant metastases or inoperable, unresectable or recurrent. 6. Astrocytoma - Grade III and IV ... Frontotemporal Dementia (FTD), Picks Disease -Type A - Adult. 19. Gallbladder Cancer. 20. Gaucher Disease (GD) - Type 2. 21. Glioblastoma Multiforme (Brain Tumor). 22. Head and Neck Cancers - with distant metastasis or inoperable or uresectable ...
View Blog: HadIt.com VA Claims Research - http://www.hadit.com/forums/index.php



View Post: FDA Grants Priority Review for Shire's velaglucerase alfa for Type ...
3 Nov 2009 by Prne  
Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA. August 2nd, 2009 LEXINGTON, Massachusetts - - Treatment ...
View Blog: PR Hub - http://blog.taragana.com/pr/



View Post: Miglustat improves lipid profile in Type 1 Gaucher disease: Lipids ...
25 Oct 2009
To determine the effect of miglustat on the lipid profile, Pilar Giraldo (Miguel Servet University, Zaragoza, Spain) and co-workers studied 26 patients with Type 1 Gaucher disease who were treated with miglustat for up to 3 years. ...
View Blog: Lipids Online News - http://www.lipidsonline.org/



View Post: Gaucher's disease at a glance
YES Disease
25 Oct 2009 by morello   ...
View Blog: http://www.yesdisease.com/



View Post: Is Parkinson disease an enzyme disorder? « Medical Search Tips ...
18 Nov 2009 by smnewsletters  
Another search, using the name of the manufacturer, reveals that the new drug has already been approved by the FDA to treat Gaucher disease, even though phase 3 trials are still under way. (We see no evidence using the option “The ...
View Blog: Medical Search Tips, News, and Information... - http://clinicalsearchtips.com/



View Post: FDA Delays Genzyme's Lumizyme, Manufacturing Problems Blamed ...
19 Nov 2009 by David Phillips  
Scrip News - 3 days 5 hours 35 minutes ago. Deficiencies at Genzyme's beleaguered Allston, Massachusetts manufacturing plant must be resolved before the US FDA will approve Lumizyme (alglucosidase alfa) for Pompe disease, the company said. ... GENZ suffered yet another setback yesterday when Protalix BioTherapeutics Inc. announced that the US Food and Drug Administration FDA has approved the treatment protocol for its experimental drug for Gaucher disease. ...
View Blog: BNET Blogs - http://blogs.bnet.com/



View Post: Upcoming Events: Key Club Awake-a-thon : Voices from the Trail
27 Oct 2009 by Nneka Nwaobi  
Their goals are to find a cure for the gaucher disease type 2 and type 3. Type 2 and type 3 are serious because it's not like type 1, which it affects the brain. The use of the fund goes to a medical research for the cure of Gaucher. ...
View Blog: Voices from the Trail - http://www.voicesfromthetrail.com/



View Post: there are too many unknowns…
9 Aug 2009 by Melissa  
i know that we're likely going to lose him to this disease anyway, but you know what, no one knows that for sure. just like no one ever imagined that 26 years ago the little girl with gaucher disease type 3 would live as long as she has ...
View Blog: Untitled - http://acherishedangel.com/



View Post: First Patient Enrolled in Phase 3 Trials of Genzyme Oral Capsule ...
20 Oct 2009 by India-News  
ENCORE is a randomized, open-label study for adult patients with Gaucher disease type 1 designed to compare Genz-112638 to Cerezyme® (imiglucerase for injection). Adult patients who have previously received Cerezyme for at least three ...
View Blog: Business & Finance News - http://trak.in/india/



Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $30 a year, a savings of 70% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

GoldBambooTM

Your Integrative Health and Wellness Resource for Gaucher disease, type 3.

November 21, 2009



Page Updated: September 6, 2005
============== Advertisement ==============
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Health Forums

Copyright © 2004-2009 - Anaconda Partners LLC - All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.